JAN 04, 2016 12:29 PM PST

'STING' Pathway Inhibited By Colorectal Cancer Cells

WRITTEN BY: Kara Marker
The stimulator of interferon genes (STING) pathway, discovered in 2008 to promote type 1 interferon production in response to a pathogenic infection, was recently found to also play a role in suppressing colorectal cancer cells (Journal of Molecular Cell Biology). Many populations of abnormally growing tumor cells inhibit STING in order to avoid immune system detection.

Type 1 interferons play a multi-faceted role in activate both the innate and adaptive immune system; interferon-related production of various cells reduces tissue damage during infection and prevents autoimmune activity (Nature Reviews Immunology). From the Sylvester Comprehensive Center at the University of Miami Miller School of Medicine, scientists investigate the role of the STING pathway in controlling cells like type 1 interferons during cases of colorectal cancer. Their study was recently published in Cell Reports.

Almost all cases of colorectal cancers are adenocarnomas that begin growth in glandular cells inside the colon or rectum. Although the death rate from colorectal cancer has been steadily dropping during the past two decades, about 50,000 people died from this cancer in 2015 (American Cancer Society). 
 

Researchers used a technique called “epigenetic hypermethylation” to mute the effect of STING signaling in order to replicate and visualize how colorectal cancer cells grow and evade the immune system. They did this by adding a methyl group to STING-specific DNA to inhibit transcription (Nature).

Without properly functioning STING signaling, DNA-damaged cells went undetected by the body’s immune cells. Inhibition of the STING pathway prevented cytokine production, which resulted in decreased tissue repair and “anti-tumor cytotoxic T cell priming” (Cell). A loss of antigen-presenting cells called dendritic cells also occurs without STING signaling. Dendritic cells are needed to recognize tumor cells circulating in the blood stream.
 


If loss of STING activity leads to unrestrained cancer growth, shouldn’t scientists figure out a way to turn STING activity back on? This is certainly a potential answer for colorectal cancer, but scientists also have to consider the careful balance of STING activity that must be kept. Overstimulation of this pathway has numerous consequences such as autoinflammatory disease and “inflammation driven skin cancer” (Cell).

Source: Cell Reports
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 02, 2021
Immunology
Another Trick up Tumors' Sleeves Exposed
MAR 02, 2021
Another Trick up Tumors' Sleeves Exposed
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat ...
MAR 07, 2021
Genetics & Genomics
Tuberculosis Influenced the Human Genome
MAR 07, 2021
Tuberculosis Influenced the Human Genome
Throughout human history, our species has come into contact with both harmless and infectious microbes that have changed ...
MAR 18, 2021
Immunology
COVID Cytokine Storm Chasers Look Inside the Lungs
MAR 18, 2021
COVID Cytokine Storm Chasers Look Inside the Lungs
Immunologists have revealed one of the underlying mechanisms behind COVID’s life-threatening cytokine storms. By s ...
MAR 30, 2021
Immunology
Single-Cell Technology Exposes Melanoma's Weak Spot
MAR 30, 2021
Single-Cell Technology Exposes Melanoma's Weak Spot
The immune system encompasses a powerful arsenal of weapons against pathogenic threats. But what stops healthy tissues i ...
MAY 04, 2021
Immunology
One Vaccine to Rule Them All
MAY 04, 2021
One Vaccine to Rule Them All
There are currently five variants of concern in the U.S., genetically distinct forms of the COVID-causing coronavirus th ...
JUN 11, 2021
Cell & Molecular Biology
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
JUN 11, 2021
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
The immune system can detect and destroy pathogenic and cancerous cells, but sometimes those dangerous cells can evade t ...
Loading Comments...